SCHEMBL22494872

SCHEMBL22494872

C=CC1(C)CC(n2ccc3c(C)ncnc32)C2OC(C)(C)OC21

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 20/20 0.40
WDR77 Q9BQA1 19/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28477494 1.00 PRMT5 (0.40) PRMT5WDR77
SCHEMBL22495027 1.00 PRMT5 (0.40) PRMT5WDR77
SCHEMBL23535972 0.89 PRMT5 (0.36) PRMT5WDR77
SCHEMBL22494884 0.89 PRMT5 (0.46) PRMT5WDR77
SCHEMBL28476776 0.89 PRMT5 (0.35) PRMT5WDR77
SCHEMBL22494864 0.89 PRMT5 (0.35) PRMT5WDR77
SCHEMBL22494921 0.89 PRMT5 (0.46) PRMT5WDR77
SCHEMBL30002812 0.89 PRMT5 (0.46) PRMT5WDR77
SCHEMBL28474368 0.82 PRMT5 (0.38) PRMT5WDR77
SCHEMBL19667207 0.80 PRMT5 (0.38) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200317686-A1 COMPOUNDS TARGETING PRMT5 ALIGOS THERAPEUTICS, INC. 2020-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200317686-A1 COMPOUNDS TARGETING PRMT5 PRMT5, PRMT1, PRMT6 PRMT5 1/4885WDR77 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.